GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRay Technology Co Ltd (SHSE:688301) » Definitions » Debt-to-Equity

iRay Technology Co (SHSE:688301) Debt-to-Equity : 0.67 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is iRay Technology Co Debt-to-Equity?

iRay Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥111 Mil. iRay Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,897 Mil. iRay Technology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥4,477 Mil. iRay Technology Co's debt to equity for the quarter that ended in Mar. 2024 was 0.67.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for iRay Technology Co's Debt-to-Equity or its related term are showing as below:

SHSE:688301' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.06   Max: 0.67
Current: 0.67

During the past 9 years, the highest Debt-to-Equity Ratio of iRay Technology Co was 0.67. The lowest was 0.01. And the median was 0.06.

SHSE:688301's Debt-to-Equity is ranked worse than
79.8% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs SHSE:688301: 0.67

iRay Technology Co Debt-to-Equity Historical Data

The historical data trend for iRay Technology Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRay Technology Co Debt-to-Equity Chart

iRay Technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only 0.14 0.03 0.02 0.37 0.48

iRay Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.39 0.37 0.48 0.67

Competitive Comparison of iRay Technology Co's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, iRay Technology Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRay Technology Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRay Technology Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where iRay Technology Co's Debt-to-Equity falls into.



iRay Technology Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

iRay Technology Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

iRay Technology Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iRay Technology Co  (SHSE:688301) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


iRay Technology Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of iRay Technology Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


iRay Technology Co (SHSE:688301) Business Description

Traded in Other Exchanges
N/A
Address
No.590 Ruiqing Road, Room 202, 2nd Floor, Building 9, Pudong New Area, Shanghai, CHN, 201201
iRay Technology Co Ltd is engaged in development and manufacturing of key X-ray system components used in medical, dental, veterinary and industrial imaging applications. The company's products portfolio includes Wireless Radiography Detectors; Tethered Radiography Detectors; Mammography Detectors; Dynamic/Real-time Detectors; Linear Detector Arrays; Software; and Other.
Executives
Director
Directors, senior managers, core technical personn

iRay Technology Co (SHSE:688301) Headlines

No Headlines